Latest Annual Reports
by Mike Gee
20 November 2026









































Charlie's Holdings, Inc.
REVENUE
$20,916,000
169.36%
INCOME
$4,499,000
208.18%
EMPLOYEES
35
CUSTOMERS
3,000
Charlie’s Holdings, Inc. is a Nevada-based premium vapor-products company that develops and sells nicotine and non‑nicotine (Metatine) disposables, e-liquids and NIC salts while investing in age‑gating/access-control IP and operating U.S. and Chinese contract manufacturing with a growing domestic filling operation.
View Company PageFiled: 2026-04-01
CHINA PHARMA HOLDINGS, INC.
REVENUE
$4,144,268
-8.49%
INCOME
-$3,200,000
32.44%
EMPLOYEES
221
CUSTOMERS
N/A
China Pharma Holdings Inc. is a Nevada holding company that, through its wholly owned PRC subsidiary Hainan Helpson, develops, manufactures and markets 19 NMPA‑approved prescription pharmaceutical products in China focused on high‑incidence and high‑mortality areas (CNS, cardiovascular, infectious/respiratory, digestive) across multiple dosage forms.
View Company PageFiled: 2026-04-01
Golden Minerals Co
REVENUE
N/A
INCOME
$2,653
134.91%
EMPLOYEES
3
CUSTOMERS
N/A
Golden Minerals is an exploration-stage precious metals company (no operating mines) focused on advancing its Argentine Sarita Este and Desierto projects and the Sand Canyon project in Nevada via joint ventures and asset monetization, having divested most Mexican assets and facing liquidity/going-concern risk.
View Company PageFiled: 2026-04-01
AMERICAN EAGLE OUTFITTERS INC
REVENUE
$5,547,236,000
4.10%
INCOME
$185,522,000
-43.25%
EMPLOYEES
45,000
CUSTOMERS
N/A
American Eagle Outfitters, Inc. is a public specialty apparel retailer and licensor operating brands including American Eagle and Aerie, selling direct-to-consumer through stores and digital channels with significant international licensing partnerships.
View Company PageFiled: 2026-03-30
APPLIED ENERGETICS, INC.
REVENUE
$461,727
-80.97%
INCOME
-$14,872,730
-62.10%
EMPLOYEES
26
CUSTOMERS
N/A
Applied Energetics, Inc. develops compact, fiber-based ultrashort-pulse laser and photonics systems for national security, biomedical, and advanced manufacturing applications.
View Company PageFiled: 2026-03-30
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
REVENUE
N/A
INCOME
-$78,082
EMPLOYEES
N/A
CUSTOMERS
N/A
Pre-revenue blank-check company (SPAC) with significant deferred offering costs and related-party promissory note financing; no reported revenues, accumulated deficit of $78,082, and total assets of $285,064 in the latest period.
View Company PageFiled: 2026-03-30
American Exceptionalism Acquisition Corp. A
REVENUE
N/A
INCOME
N/A
EMPLOYEES
N/A
CUSTOMERS
N/A
Unnamed Cayman Islands SPAC holding approximately $348,366,162 in a trust account, with total assets of $349,248,591, total liabilities of $20,801,168 and an accumulated deficit of $19,920,235.
View Company PageFiled: 2026-03-30
AmBase Corp
REVENUE
N/A
INCOME
-$4,560,000
31.12%
EMPLOYEES
6
CUSTOMERS
N/A
AmBase Corporation is a Delaware holding company that primarily manages its impaired equity investment in the 111 West 57th Street real estate development, holds mostly cash, reports no operating revenue, and relies on related-party loans and litigation funding while pursuing litigation and sale options to realize value.
View Company PageFiled: 2026-03-30
21Shares Solana ETF
REVENUE
N/A
INCOME
N/A
EMPLOYEES
N/A
CUSTOMERS
N/A
TSOL is a Delaware statutory trust that issues shares trading on the Cboe BZX under the symbol TSOL, acting as a passive, ETF‑like vehicle to track the price of Solana (SOL) using the CME CF Solana‑Dollar Reference Rate and to reflect staking rewards net of fees.
View Company PageFiled: 2026-03-30
ALLURION TECHNOLOGIES, INC.
REVENUE
$15,230,000
-52.57%
INCOME
-$28,755,000
-299.49%
EMPLOYEES
41
CUSTOMERS
200,000
Allurion develops and sells a metabolically focused weight‑loss platform centered on the Allurion Smart Capsule — a swallowable, procedureless intragastric balloon — paired with a digital care ecosystem (Allurion Virtual Care Suite, patient app, connected scale, and provider Insights dashboard) delivered via a B2B2C model across 50+ countries.
View Company PageFiled: 2026-03-30
60 DEGREES PHARMACEUTICALS, INC.
REVENUE
N/A
INCOME
-$7,368,325
7.38%
EMPLOYEES
N/A
CUSTOMERS
N/A
Specialty pharmaceutical company focused on infectious diseases, developing and commercializing therapies including Arakoda (tafenoquine) for malaria prevention and advancing programs in babesiosis, celgosivir/castanospermine extracts, and veterinary applications.
View Company PageFiled: 2026-03-30
Allarity Therapeutics, Inc.
REVENUE
$320,000
INCOME
-$11,231,000
54.19%
EMPLOYEES
8
CUSTOMERS
N/A
Clinical-stage precision-medicine pharmaceutical company developing stenoparib (a dual PARP1/2 and tankyrase inhibitor) and the DRP® companion diagnostic platform to identify patients most likely to benefit from targeted cancer therapies.
View Company Page